Authors: Tartour, E Mehtali, M Sastre-Garau, X Joyeux, I Mathiot, C Pleau, J Squiban, P Rochlitz, C Courtney, M Jantscheff, P Herrmann, R Pouillart, P Fridman, WH Dorval, T

Citation: E. Tartour et al., Phase I clinical trial with IL-2-transfected xenogeneic cells administeredin subcutaneous metastatic tumours: clinical and immunological findings, BR J CANC, 83(11), 2000, pp. 1454-1461